Evaluation of Autologous Natural Killer Cell Activity in Primary Cancer Cell Cultures

Withdrawn before enrolling

Conditions studied: Sarcoma

In brief

The objectives of the study is to evaluate the anti-tumor activity of autologous natural killer cells in cultures of cancer cells obtained from patient's own tumor.

Key facts

Study ID

NCT05869994

Run by

Sarcoma Oncology Research Center, LLC

People needed

0

Starts

2023-01-27

Expected to finish

2024-07-01

Last updated by the study team

2024-07-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Individuals must meet all of the inclusion criteria in order to be eligible to participate in the study, as follows:
• Male or Female ≥ 18 years of age
• Pathologically confirmed diagnosis of locally advanced unresectable or metastatic soft tissue sarcoma
• Patients who are already scheduled for surgery
• Ability to understand the purposes and risks of the study and has signed and dated a written informed consent form approved by the investigator's IRB/Ethics Committee
• Willingness to comply with all study procedures and availability for the duration of the study.

You may not qualify if…

• Patients who do not meet inclusion criteria.

Where it is running

• Sarcoma Oncology Research Center — Santa Monica, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.